Brain Implants Offer Hope for Parkinson’s Treatment

Professor George Malliaras from Cambridge, alongside Professor Roger Barker and an international team, is leading a project to develop advanced brain implants using tiny clusters of brain cells. Funded by the UK’s Advanced Research + Invention Agency (ARIA) as part of an $85 million initiative, the research aims to create more precise neural interfaces, tested in animal models of Parkinson’s disease. This project is part of ARIA’s Precision Neurotechnologies program, which supports innovative brain-computer interface research across academia, startups, and R&D institutions. Over four years, ARIA will fund new ways to interact with the brain at the neural circuit level, aiming to improve treatments for conditions like Parkinson's, Alzheimer’s, epilepsy, and depression. Parkinson’s disease affects 130,000 people in the UK. Current treatments, such as dopamine-based drugs, lose effectiveness over time and cause side effects. One potential solution is transplanting dopamine-producing cells, but they must properly integrate into brain networks to be effective. The ARIA-funded research explores using tiny clusters of brain cells combined with advanced materials and electrical stimulation to rebuild damaged neural pathways.